Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations

Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are routinely used to treat non-small cell lung cancer (NSCLC) in patients with common activating mutations of the EGFR gene. The aim of the study was to compare the efficacies of EGFR-TKIs in patients with common (exon 19 delet...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Krawczyk, Pawel, Kowalski, Dariusz M., Ramlau, Rodryg, Kalinka-Warzocha, Ewa, Winiarczyk, Kinga, Stencel, Katarzyna, Powrózek, Tomasz, Reszka, Katarzyna, Wojas-Krawczyk, Kamila, Bryl, Maciej, Wójcik-Superczyńska, Magdalena, Głogowski, Maciej, Barinow-Wojewódzki, Aleksander, Milanowski, Janusz, Krzakowski, Maciej
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5453045/
https://ncbi.nlm.nih.gov/pubmed/28599445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.5980
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados